QA: Skye Bioscience Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2019_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001516551')"}

Graph

Absolute values for 0001516551, Skye Bioscience Inc.

  xvar xval
0 AssetsCurrent 1,953,687
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,445
3 remainder_Assets 0
4 LiabilitiesCurrent 15,938,971
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,580,413
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,362,557
9 ResearchAndDevelopmentExpense 329,966
10 remainder_Expenses 6,599,579
11 remainder_Revenues 0
12 remainder_NetIncome -7,902,134
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,957,132
1 Liabilities 17,519,384
2 Expenses 11,292,102
3 Revenues 0
4 StockholdersEquity -15,562,252
5 NetIncome -19,194,236
6 ComprehensiveNetIncome -19,194,236
7 BaseVar 19,335,376
8 EconomicCapitalRatio -4.72

Edgar->Model Mapping

Feature Distribution

Change over Time